✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Revolution Medicines Inc

Common Name
Revolution Medicines
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
809
Ticker
RVMD
Exchange
NASDAQ/NGS
Description
Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for cancers driven by the RAS protein, one of the most common cancer drivers affecting approxima...

Revolution Medicines's Financial Statements Preview

Below are the financial statements of Revolution Medicines, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
543.06a
696.15a
Marketable securities
1,746.24a
1,156.81a
Accounts receivable
0a
1.25a
Prepaid expenses and other current assets
38.33a
25.07a
Total current assets
2,327.63a
1,879.28a
Property and equipment, net
24.29a
22.87a
Operating lease right-of-use asset
117.53a
77.15a
Intangible assets, net
56.67a
57.74a
Goodwill
14.61a
14.61a
Restricted cash
3.7a
3.03a
Other noncurrent assets
13.87a
7.03a
Total assets
2,558.3a
2,061.71a
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
54.43a
61.79a
Accrued expenses and other current liabilities
96.62a
74.69a
Operating lease liability, current
12.87a
7.37a
Total current liabilities
163.91a
143.85a
Deferred tax liability
2.35a
3.12a
Operating lease liability, noncurrent
122.97a
80.58a
Warrant liability
3.19a
6.51a
Other noncurrent liabilities
0.67a
1.46a
Total liabilities
293.1a
235.51a
Stockholders’ equity
Preferred stock
0a
0a
Common stock
0.02a
0.02a
Additional paid-in capital
4,001.67a
2,963.34a
Accumulated other comprehensive income
1.32a
0.54a
Accumulated deficit
-1,737.8a
-1,137.71a
Total stockholders’ equity
2,265.2a
1,826.19a
Total liabilities and stockholders’ equity
2,558.3a
2,061.71a
Limited Data Preview
You are viewing a limited preview of Revolution Medicines’s balance sheet data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Revolution Medicines’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Revolution Medicines’s data sources below and access millions more through our Disclosure Search.

a. Revolution Medicines's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?